Vetoquinol
Update in progressVETO.PA (Paris)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Vetoquinol SA is a veterinary pharmaceutical company that designs, develops, and sells medicines and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia-Pacific region. Its range covers mobility, pain and inflammation; dermatology, hygiene, and care; anti-parasites; udder health; antibiotics; reproduction; behavior; internal medicine; and cardio-nephrology. Founded in 1933, based in Lure, France, and a subsidiary of Soparfin SCA.
Company score
- Sentiment
- -0.01
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.09
- Governance
- -0.05
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.04
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.02
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketParis (PAR)
- LocationFrance
- CEOMr. Matthieu Frechin
- Founded1933
- Employees2,422
- Websitewww.vetoquinol.com
Identifiers
- ISINFR0004186856